Louis de Mestier

19PUBLICATIONS
59CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsHaematological tumoursRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 27, 2026
Developing a Histology-Based Artificial Intelligence Biomarker to Predict Adjuvant Chemotherapy Benefit in Pancreatic Cancer.

|Jun 24, 2026
Characteristics, management, and outcomes of patients with VIPoma-A retrospective analysis of the ENETS database.

|Jan 05, 2026
Comparison of radiological and pathological tools to assess response to neoadjuvant treatment in resected pancreatic ductal adenocarcinoma patients.

Anaïs Jenvrin, Riccardo Sartoris, Safi Dokmak

|Dec 03, 2025
Chemoembolization using streptozotocin versus embolization in metastatic NETs.

Anne-Laure Védie, Francesco Matteini, Jérôme Cros

|Sep 16, 2025
Predictive value of metabolic state on PanNET response to mTOR inhibitors.

Jérôme Cros, Margot Bucau, Matthieu Tihy

|Jan 13, 2025
Temporal increase in Ki-67 index in patients with pancreatic neuroendocrine tumours.

Pauline Bourdeleau, Johanna Pokossy-Epée, Olivia Hentic

Pageof 4

Frequent Collaborators

7 joint publications

Jérôme Cros

4 joint publications

Matthieu Tihy

2 joint publications

Remy Nicolle

1 joint publications

F Spada